Corporate News     12-Jul-21
FDC launches India's first oral suspension of Favipiravir
Used in treatment of mild to moderate case of Covid-19
FDC announced the launch of India's first oral suspension of Favipiravir – Favenza Oral Suspension, used to treat mild to moderate cases of COVID-19. This prescription-only solution is currently available at all retail medical outlets and hospital pharmacies across the country.

The Favenza suspension is unique due to its Convenient Loading Dose (Day 1) of 18 ml in the morning and 18 ml in the evening. The results of which are equivalent to 9 tablets of Favipiravir 400mg making the process of Covid-19 treatment hassle free.

Previous News
  FDC
 ( Results - Analysis 07-Aug-24   16:56 )
  FDC
 ( Results - Analysis 30-May-24   09:38 )
  FDC to announce Quarterly Result
 ( Corporate News - 03-Aug-21   13:43 )
  FDC consolidated net profit rises 1.48% in the December 2020 quarter
 ( Results - Announcements 05-Feb-21   17:42 )
  FDC schedules AGM
 ( Corporate News - 21-Jul-17   12:39 )
  Volumes spurt at Honeywell Automation India Ltd counter
 ( Hot Pursuit - 16-May-24   14:30 )
  Volumes jump at FDC Ltd counter
 ( Hot Pursuit - 21-Apr-23   14:30 )
  FDC consolidated net profit rises 34.14% in the September 2019 quarter
 ( Results - Announcements 09-Nov-19   10:06 )
  FDC consolidated net profit declines 77.72% in the March 2022 quarter
 ( Results - Announcements 26-May-22   08:07 )
  FDC standalone net profit rises 45.46% in the September 2019 quarter
 ( Results - Announcements 09-Nov-19   09:59 )
  FDC announces board meeting date
 ( Corporate News - 23-Jan-20   17:06 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top